In a non-patient population, a take-home placebo spray labelled oxytocin reduced symptoms of depression compared with a wait-list control.
In plain wordsIn healthy adults, a placebo spray labelled oxytocin reduced symptoms of depression compared with no treatment. It contained no oxytocin.
- Peptide
- Oxytocin
- Outcome
- DecreaseSymptoms of depression
- Study
n: not reported in source
- Comparator
- Wait-list control
- Outcome group
- Anxiety and mood · Mental health and mood
Source sentences
Both the 'serotonin' and 'oxytocin' treatment sprays were effective in reducing symptoms of depression; however, only those in the 'oxytocin' group reported less stress and anxiety as compared with controls.
2 context sentences(design, population, supporting numbers)
A sample of 77 participants was randomized to either the 'oxytocin' treatment group (n = 22), the 'serotonin' treatment group (n = 22) or the wait-list control group (n = 33).
The two treatment groups were given an 'anti-stress treatment spray' (placebo) to self-administer for 3 days, and completed online measures of perceived stress (Perceived Stress Scale-10), anxiety (Cognitive Somatic Anxiety Questionnaire) and symptoms of depression (Centre for Epidemiological Studie…
In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.